3 result(s) for online presence in Health & Wellness
Medical Universities Mapping Virus In Hungary Via New Screening Programme
- 29 Apr 2020 10:36 AM
- hungarymatters.hu
- health & wellness
Hungary’s medical universities are launching a screening programme on Friday to estimate the actual number of people infected with novel coronavirus and their spread across the country, Béla Merkely, the head of Budapest’s Semmelweis University, said.
Chief Medical Officer: Hungarian Research On Virus Antibody 'Promising'
- 25 Apr 2020 7:19 AM
- health & wellness
Hungarian research into the antibody to the novel coronavirus is showing promising results, and doctors have started to administer it to a patient on Thursday, Chief Medical Officer Cecília Müller said.
Women Suffering From Myoma Could Avoid Surgery In Hungary
- 29 May 2015 9:00 AM
- health & wellness
Hungary-based drugmaker company Gedeon Richter Plc. announced on Thursday, that the European Commission (EC) has granted approval for the intermittent use of the company’s ‘Esmya’ 5 mg tablets in the long term management of uterine fibroids. This decision follows a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) on 23 April ...
Medical Universities Mapping Virus In Hungary Via New Screening Programme
- 29 Apr 2020 10:36 AM
- hungarymatters.hu
- health & wellness
Hungary’s medical universities are launching a screening programme on Friday to estimate the actual number of people infected with novel coronavirus and their spread across the country, Béla Merkely, the head of Budapest’s Semmelweis University, said.
Chief Medical Officer: Hungarian Research On Virus Antibody 'Promising'
- 25 Apr 2020 7:19 AM
- health & wellness
Hungarian research into the antibody to the novel coronavirus is showing promising results, and doctors have started to administer it to a patient on Thursday, Chief Medical Officer Cecília Müller said.
Women Suffering From Myoma Could Avoid Surgery In Hungary
- 29 May 2015 9:00 AM
- health & wellness
Hungary-based drugmaker company Gedeon Richter Plc. announced on Thursday, that the European Commission (EC) has granted approval for the intermittent use of the company’s ‘Esmya’ 5 mg tablets in the long term management of uterine fibroids. This decision follows a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) on 23 April ...